This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Here's Why You Should Retain CLOV Stock in Your Portfolio for Now
by Zacks Equity Research
Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.
CRLNegative Net Change MDPositive Net Change ATRCNegative Net Change CLOVNegative Net Change
medical medical-devices
New Strong Sell Stocks for January 20th
by Zacks Equity Research
DAR, CADL and DRTS have been added to the Zacks Rank #5 (Strong Sell) List on January 20, 2026.
DARNegative Net Change CADLNegative Net Change DRTSNegative Net Change
consumer-staples medical medical-devices
Should You Still Hold GMED Stock in Your Portfolio?
by Zacks Equity Research
Globus Medical is growing musculoskeletal market share with new product launches, strong finances and international expansion plans.
BSXPositive Net Change GMEDPositive Net Change PAHCPositive Net Change NVSTPositive Net Change
medical medical-devices
How Tilray Brands Is Acting on Its Vast International Opportunity
by Moumi Mondal
TLRY posts a standout international quarter as cannabis revenues jump 36% year over year, driving supply shifts and broader global expansion.
TLRYNegative Net Change VFFNegative Net Change SNDLNegative Net Change
medical medical-devices
Elekta Wins FDA Nod for Evo CT-Linac, Boosting U.S. Radiation Oncology
by Zacks Equity Research
EKTAY jumps after FDA clears Evo CT-Linac, opening U.S. access to AI-driven CT imaging that boosts precision and efficiency in radiation therapy.
ISRGNegative Net Change ATRCNegative Net Change EKTAYNegative Net Change VCYTNegative Net Change
medical medical-devices
SNN Boosts Shoulder Repair Portfolio With Integrity Orthopaedics Deal
by Zacks Equity Research
SNN expands its Sports Medicine portfolio with Integrity Orthopaedics, adding next-gen Tendon Seam tech to strengthen leadership in shoulder repair.
BSXPositive Net Change SNNPositive Net Change IDXXNegative Net Change STEPositive Net Change
medical medical-devices
Here's Why You Should Hold DaVita Stock in Your Portfolio for Now
by Zacks Equity Research
DVA stock benefits from a patient-centric model, third-quarter revenue growth and overseas expansion, though reliance on commercial payers remains a risk.
BSXPositive Net Change DVAPositive Net Change IDXXNegative Net Change STEPositive Net Change
medical medical-devices
Hims & Hers Expands Platform-Led Access to Digital Healthcare
by Debanjana Dey
HIMS leverages a software-driven platform to scale personalized digital care across new health categories and markets.
TDOCNegative Net Change AMWLNegative Net Change HIMSNegative Net Change
medical medical-devices
AI, Digital Tools and Hub Data: Could ISRG Evolve Beyond Robotics?
by Indrajit Bandyopadhyay
Intuitive Surgical is positioning da Vinci 5 as a data-driven platform, using AI, software and surgical data to expand beyond robotics into insights.
BSXPositive Net Change ISRGNegative Net Change GEHCPositive Net Change
medical medical-devices
HOLX vs. SYK: Which Medical Device Leader Is a Solid Bet Now?
by Moumi Mondal
Hologic and Stryker gear up for earnings with diagnostic wins, surgical growth and strategic moves shaping the medical device race.
SYKPositive Net Change HOLXNegative Net Change
medical medical-devices